Imiquimod 5% / Niacinamide 4%
Product Images NDC 72934-1127

3 FDA label images from Sincerus Florida, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Imiquimod 5% / Niacinamide 4% (NDC 72934-1127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dg (2 End)

Dg (2 End)
Side label of IMIQUIMOD 5% / NIACINAMIDE 4% topical drug product from Sincerus Florida, LLC. The label includes directions for use, manufacturer address in Pompano Beach, FL, contact numbers, and a QR code. The label advises to apply topically, indicates external use only, and storage at controlled room temperature (20-25°C).*
FDA Label Image

Zd (1127 2 Front)

Zd (1127 2 Front)
IMIQUIMOD 5% / NIACINAMIDE 4% gel in a 30gm white container with a label showing the NDC number 72934-1127-2. The label includes the manufacturer name Sincerus Florida with a logo and states that this is a compounded drug made in the USA.*
FDA Label Image

F (1127 2 Middle)

F (1127 2 Middle)
Side label of IMIQUIMOD 5% / NIACINAMIDE 4% gel container by Sincerus Florida, LLC. The label lists active ingredients Imiquimod USP 5% and Niacinamide USP 4%, and inactive ingredients Glycerin USP 84%, Suspensisse Gel 10%, and Tea Tree Oil 2%. The label also includes batch information and dates for BUD and MFG.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.